In September 2025 , Eli Lilly and Company invested $6.5 billion to build a new manufacturing facility in Houston, Texas, dedicated to producing its experimental oral GLP-1 pill, orforglipron
Nearly 8,000 adults in Ohio and Florida who had been on semaglutide or tirzepatide for 3 to 12 months were tracked for one year after stopping
Rather than offering a one-size-fits-all plan, Zealthys providers tailor GLP-1 treatment to the individual
During your metabolic and peptide therapy appointment, your provider will evaluate and select the most suitable GLP-1 agonist, peptide, or NAD+ supplement to align with your body's specific needs
Smaller doses (0.25 mg, 0.5 mg, and 1 mg) cost $349 a month for existing patients
According to a report by the Ministry of Health and Family Welfare, over 30% of patients express a preference for therapies specifically customized to their health profiles and genetic markers